Differentiation status of primary immune cells in different tissues from patients with HNSCC
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Differentiation status of primary immune cells in different tissues from patients with HNSCC ; volume:98 ; number:S 02 ; year:2019 ; 02
Konferenz: Abstract- und Posterband – 90. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Digitalisierung in der HNO-Heilkunde; 2019-05-29; Estrel Congress Center Berlin; Deutsche Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn
Laryngo-Rhino-Otologie ; 98, Heft S 02 (2019), 02
- Beteiligte Personen und Organisationen
-
Durisin, M.
Beier, C.
Grabski, E.
Kalinke, U.
Frenz, T.
- DOI
-
10.1055/s-0039-1685983
- URN
-
urn:nbn:de:101:1-2019092312130240929472
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Durisin, M.
- Beier, C.
- Grabski, E.
- Kalinke, U.
- Frenz, T.
Ähnliche Objekte (12)
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
Immune surveillance of cytomegalovirus in tissues
Overexpression of TPD52L2 in HNSCC: prognostic significance and correlation with immune infiltrates
HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC
Physikalische Charakterisierung von HNSCC-Zellen
Physical characterization of HNSCC cells
Immuntherapie des HNSCC: quo vadis?
Profiling DNA methylation in primary osteoarthritis tissues
Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
Immune surveillance of cytomegalovirus in tissues
Overexpression of TPD52L2 in HNSCC: prognostic significance and correlation with immune infiltrates
HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC
Physikalische Charakterisierung von HNSCC-Zellen
Physical characterization of HNSCC cells
Immuntherapie des HNSCC: quo vadis?
Profiling DNA methylation in primary osteoarthritis tissues
Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
Immune surveillance of cytomegalovirus in tissues
Overexpression of TPD52L2 in HNSCC: prognostic significance and correlation with immune infiltrates
HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC
Physikalische Charakterisierung von HNSCC-Zellen
Physical characterization of HNSCC cells
Immuntherapie des HNSCC: quo vadis?
Profiling DNA methylation in primary osteoarthritis tissues
Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC